CMEology

Overview

With over 25 years in developing continuing education activities, we know how to engage health care providers. At CMEology, our ideas begin and end with the patient. Our activities embrace the National Quality Strategy and are designed to improve the effectiveness of patient care. We strive to provide meaningful learning experiences that inspire and empower. Our outcomes include quantitative assessments with descriptive statistics and subgroup analyses, qualitative results, and outcomes impact analysis and modeling.


Bipolar Depression Across the Life Span: Enhancing Diagnosis and Management From Youth to Older Age

Bipolar disorder affects individuals of various ages, but the diagnosis, treatment, and outcomes are not the same in all patient populations. Although bipolar disorder is most commonly diagnosed in early adulthood, about half of adults with the disorder experienced onset in childhood or adolescence.1 Up to 2 million US children and adolescents suffer from bipolar spectrum disorders.2 Childhood-o...
CMEology

Getting to Remission: Differentiating Residual Symptoms from Treatment Side Effects in Major Depressive Disorder

Millions of US adults with MDD are inadequately treated despite the availability of effective therapies. Achieving and maintaining remission continues to be a considerable clinical challenge. In addition, cognitive impairment is a common residual symptom, and many clinicians are failing to assess for and manage this aspect of depression. Some residual symptoms, such as weight gain, sleep disturb...
CMEology

Improving Autosomal Dominant Polycystic Kidney Disease Management Across the Continuum of Care: Focus on Nephrology

This activity will feature a patient at high risk for progression of autosomal dominant polycystic kidney disease (ADPKD) and chronicle her journey through diagnosis, assessment, treatment planning, and monitoring. It will address the role of the specialist and will include factors that influence progression of ADPKD, kidney size determined by MRI, estimating risk of progression, and disease-mod...
CMEology

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.